This study will is a pre-specified secondary analysis of the International's Surgical Outcomes Study (ISOS). The aims of this analysis is to describe the prevalence of post-operative infection in an international sample of surgical patients. We will also investigate risk factors for the development of infection and the association between infection and morbidity and mortality following elective surgery

Achary, C

Hewson, R

Patel, A

Pearse, R

Phull, M

Wan, Y

English

Queen Mary Research Online

1  Version 1.1 22/02/19 International Surgical Outcomes Study (ISOS) sub-study: post-operative infection  Statistical analysis plan  Working title Prospective observational cohort study of post-operative infection and mortality following elective surgery within ISOS  Y. I. Wan,1,2 A. Patel,1 C. Achary,2 R. Hewson,2 M. Phull,3 R. M. Pearse.1,2  1. William Harvey Research Institute, Queen Mary University of London, UK EC1M 6BQ. 2. Barts Health NHS Trust, London E1 1BB. 3. Barking, Havering and Redbridge University Hospitals, NHS Trust, UK. 2  Version 1.1 22/02/19 Background There are more than 310 million surgical procedures worldwide each year.1 In the UK, one in ten adults has a surgical procedure each year, and the annual number of procedures is increasing steadily.2 Estimates of post-operative morbidity and mortality vary, but approximately seven million patients worldwide experience a post-operative complication each year.3-5 Post-operative infections increase morbidity and mortality, and prolong intensive care and hospital stays.6  Post-operative infections are an important cause of post-operative death, although estimates vary widely. For example, organ space infection has reported mortality rates between 4 and 9%, and mortality ranges from 28 to 46% in those patients who progress to septic shock.7 8 Many post-operative infections do not progress to severe sepsis or septic shock and the mode of death for such patients is unclear. Previously reported rates of mortality for different types of infection vary widely depending on the population. The literature remains unclear about the overall rates of post-operative infection and subsequent outcomes. The relationships between different types of infection, surgical procedures, and other adverse outcomes are also unclear.  There are few large epidemiological studies which explore the risk factors and outcomes of post-operative infection. Increasing knowledge and ability to provide accurate and generalisable estimates of the key risk factors for infection and subsequent patient outcomes will aid prevention of serious post-operative infections, particularly on a global level  The International Surgical Outcomes Study aimed to provide a detailed description of post-operative complications across a large international cohort.9 The aim of this secondary analysis is to describe the prevalence of post-operative infection in an international sample of surgical patients. We will also investigate risk factors for the development of infection and the association between infection and morbidity and mortality following elective surgery. 3  Version 1.1 22/02/19 Aim To describe the incidence and types of post-operative infection which occur following elective surgery; baseline risk factors for its development; and its association with adverse clinical outcomes within 30 days (specific endpoints defined below).  Objectives 1. To describe the incidence, type, and severity of post-operative infection 2. To identify baseline risk factors for the development of post-operative infection: - patient characteristics - anaesthetic and surgical factors 3. To determine 30-day mortality for patients who do and do not develop different types of post-operative infection 4. To determine if post-operative infection influences process measures - critical care length of stay - hospital length of stay  Data collection Study cohort The International Surgical Outcome Study (ISOS) is an international multi-centre cohort study of perioperative morbidity and mortality in patients undergoing elective surgery (ISRCTN51817007).9 Data collection occurred during a seven-day period between April and August 2014 in 474 hospitals in 27 countries. All patients admitted to participating centres for elective surgery with a planned overnight stay were eligible. Patients undergoing day-case surgery or radiological procedures were excluded because they followed a dedicated pathway of care. The total sample size collected is 44,863. Patients were followed up for a maximum of 30 days after surgery.  Sample The dataset for this secondary analysis includes only patients from the ISOS cohort with mortality outcome data resulting in a sample size of 44,814.  Key variables The paper case report form (CRF) in shown in appendix 1. Independent variables which will be included in analyses for patient characteristics and anaesthetic and surgical factors are listed in table (i). The outcome variable infection is a composite measure of six different types of infection where more than 4  Version 1.1 22/02/19 one type can occur in the same patient: superficial surgical site, deep surgical site, body cavity, pneumonia, urinary tract, and bloodstream. Each type is graded by severity (mild/moderate/severe/none). Additional outcomes measures will include mortality, critical care length of stay and hospital length of stay.  Three variables are listed for treatment for post-operative complications: Drug therapy, blood transfusion or parenteral nutrition (Y/N) Surgical or radiological procedure (Y/N) Critical care admission (Y/N) We will only look at this variable in the subset of patients who did not have any other complications not related to infection: cardiovascular or other complications. This is to ensure that any variable selected for treatment for post-operative complications is due to treatment for an infective complication. 5  Version 1.1 22/02/19 Table (i). List of key independent variables. Variable Type of data Note Patient characteristics Age in years Continuous  Sex (M/F) Binary  Current smoker (Y/N) Binary  ASA (I-IV) Categorical  Coronary artery disease (Y/N) Binary Chronic disease diagnosis Diabetes mellitus (Y/N) Binary Metastatic cancer (Y/N) Binary COPD/asthma (Y/N) Binary Heart failure (Y/N) Binary Cirrhosis (Y/N) Binary Stroke (Y/N) Binary Other (Y/N) Binary Haemoglobin g/L Continuous Most recent blood result Sodium mmol/L Continuous Leukocytes x109/L Continuous Creatinine µmol/L Continuous Anaesthetic and surgical factors General anaesthetic Binary Anaesthetic technique Spinal Binary Epidural Binary Sedation/local Binary Surgical procedure (Orthopaedic/Breast/Obstetrics and gynaecology/Urology and kidney/Upper gastro-intestinal/Lower gastro-intestinal/Hepato-biliary/Vascular/Head and neck/Plastics and cutaneous/Cardiac/Thoracic/Other) Categorical  Severity of surgery (Minor/Intermediate/Major) Categorical  Laparoscopic surgery (Y/N) Binary  Cancer surgery (Y/N) Binary  Surgical checklist used (Y/N) Binary  Critical care immediately after surgery (Y/N) Binary  6  Version 1.1 22/02/19 Statistical analysis Baseline characteristics for patients who experienced no infection compared to infection will be summarised but not subjected to statistical testing. Numbers (%), means (SD) and medians (IQR) will be provided separately for each group. Incidence of infection will be presented by type and severity.   The primary outcome will be the development of post-operative infection within 30 days following surgery.  The primary outcome will be defined as being recorded if data are available for each of the following components:  • Superficial surgical site  • Deep surgical site  • Body cavity  • Pneumonia • Urinary tract  • Bloodstream  The primary outcome is defined as missing if data are missing for the above six components. Cases missing outcome data for post-operative infection will be excluded from the analysis (Figure 1).   The primary outcome will be analysed using a mixed effects logistic regression model, with a random intercept for country and site. The model will be adjusted for the following pre-specified baseline covariates: age, gender, coronary artery disease, heart failure, diabetes mellitus, cirrhosis, metastatic cancer, stroke, COPD/asthma, other co-morbid diseases, ASA score (I & II vs. III & IV), surgical procedure, severity of surgery. Age will be included as a continuous variable, assuming a linear association with the outcome. Categorical variables with two or more categories will be included using indicator variables. Results will be presented as odds ratios with a 95% confidence interval.   All analyses will be undertaken using STATA 15 (StataCorp, USA).   Secondary outcomes The secondary outcome measures will be 30-day mortality and hospital length of stay. We will use univariate logistic regression and present crude 30-day mortality (dependent variable) rates for patients with or without post-operative infection (independent variable).  Secondary outcomes will be analysed using the same approach as the primary outcome. Analyses will also be repeated for each infection type. Forest plots comparing mortality for each infection type will be presented to show each OR with 95% CI. We will report rates of different treatments for post-operative infectious 7  Version 1.1 22/02/19 complications by type of infection. We will test association between infection and hospital length of stay using a mixed effects linear regression model and present these in the supplementary material.   8  Version 1.1 22/02/19 References 1. Weiser TG, Haynes AB, Molina G, et al. Size and distribution of the global volume of surgery in 2012. Bull World Health Organ 2016; 94: 201-9F 2. Abbott TEF, Fowler AJ, Dobbs TD, Harrison EM, Gillies MA, Pearse RM. Frequency of surgical treatment and related hospital procedures in the UK: a national ecological study using hospital episode statistics. Br J Anaesth 2017; 119: 249-57 3. Pearse RM, Moreno RP, Bauer P, et al. Mortality after surgery in Europe: a 7 day cohort study. Lancet 2012; 380: 1059-65 4. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 2008; 372: 139-44 5. Ahmad T, Bouwman RA, Grigoras I, et al. Use of failure-to-rescue to identify international variation in postoperative care in low-, middle- and high-income countries: a 7-day cohort study of elective surgery. Br J Anaesth 2017; 119: 258-66 6. International Surgical Outcomes Study g. Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries. Br J Anaesth 2017; 119: 553 7. Ghaferi AA, Birkmeyer JD, Dimick JB. Variation in hospital mortality associated with inpatient surgery. N Engl J Med 2009; 361: 1368-75 8. Shankar-Hari M, Harrison DA, Rubenfeld GD, Rowan K. Epidemiology of sepsis and septic shock in critical care units: comparison between sepsis-2 and sepsis-3 populations using a national critical care database. Br J Anaesth 2017; 119: 626-36 9. International Surgical Outcomes Study group. Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries. Br J Anaesth. 2016; 117(5):601-609. 9  Version 1.1 22/02/19 Figures and tables Figure 1. STROBE flow diagram of study population Total ISOS study cohort (n=44,814) Excluded: missing infection outcome (n=)  Patients included into sub-study (n=) Reason for further exclusion (if applicable) (n=)  Dataset analysed (n=) 10  Version 1.1 22/02/19 Table 1. Baseline patient characteristics. All data presented as n (%) unless specified otherwise. ASA, American Society of Anesthesiologists physical status score; COPD, chronic obstructive pulmonary disease.  All patients Patients with infection Patients without infection n=44814 n= n= Age in years (mean SD)    Age in years (median range)    Male    Smoker    ASA score I    II    III    IV    Co-morbid disease Coronary artery disease    Heart failure    Diabetes mellitus    Cirrhosis    Metastatic cancer    Stroke    COPD / asthma    Other    Most recent result before surgery  Haemoglobin g/L (median range)    Leukocytes x109/L (median range)    Sodium mmol/L (median  range)    Creatinine µmol/L (median range)    Anaesthetic technique General    Spinal    Epidural    Sedation/Local    Surgical procedure Orthopaedic    Breast    Obstetrics and gynaecology    Urology and kidney    Upper gastro-intestinal    Lower gastro-intestinal    Hepato-biliary    Vascular    Head and neck    Plastics and cutaneous    Cardiac    Thoracic    Other    Severity of surgery    Minor    Intermediate    11  Version 1.1 22/02/19 Major    Other measures Laparoscopic surgery    Cancer surgery    Use of surgical checklist    Critical care immediately after surgery    12  Version 1.1 22/02/19 Table 2. Infection after surgery.  Univariate (unadjusted) and multivariable (adjusted) logistic regression models for development of post-operative infection. Data presented as odds ratios and 95% confidence intervals (CI). ASA, American Society of Anesthesiologists physical status score; COPD, chronic obstructive pulmonary disease.  Infection n (%) Unadjusted OR (95% CI) Adjusted OR (95% CI) p-value Age  --- --- --- Male     Current smoker     ASA score I  Reference --- --- II     III     IV     Co-morbidity Coronary artery disease     Heart failure     Diabetes mellitus     Cirrhosis     Stroke     COPD/Asthma     Other     Surgical procedure Orthopaedics     Breast     Obstetrics and gynaecology     Urology & kidney     Upper gastro-intestinal     Lower gastro-intestinal     Hepato-biliary     Vascular     Head and neck     Plastics and cutaneous     Cardiac     Thoracic      Other     Severity of surgery Minor  Reference --- --- Intermediate     Major     Other measures Laparoscopic surgery     Cancer surgery     Use of surgical checklist      13  Version 1.1 22/02/19 Table 3. Post-operative infections and mortality. Data presented as n (%). Some patients may have developed more than one complication, and consequently in some cases the denominator is the number complications whilst in the left most column the denominator is the number of patients. The cell at the bottom of the far right column represents the number of deaths divided by the number of patients with at least one complication. Univariate (unadjusted) and multivariable (adjusted) logistic regression models for development of post-operative infection for each type and total number of infections. Adjusted variables include patient characteristics and anaesthetic and surgical factors used in primary analyses. Data presented as odds ratios and 95% confidence intervals (CI).  n Severity of complications Mortality Unadjusted OR (95% CI) Adjusted OR (95% CI) p-value Mild Moderate Severe No infection  - - -  - - - Infection    Superficial surgical site 1320 (2.9) 681/1320 (51.6) 517/1320 (39.2) 122/1320 (9.2) 17/1320 (1.3)    Deep surgical site 566 (1.3) 120/566 (21.2) 250/566 (44.2) 196/566 (34.6) 28/566 (4.9)    Body cavity 340 (0.8) 97/340 (28.5) 136/340 (40.0) 107/340 (31.5) 24/340 (7.0)    Pneumonia 708 (1.6) 240/708 (33.9) 325/708 (45.9) 143/708 (20.2) 55/708 (7.8)    Urinary tract 681 (1.5) 294/681 (43.2) 333/681 (48.9) 54/681 (7.9) 13/681 (1.9)    Bloodstream 417 (0.9) 140/417 (33.6) 162/417 (38.8) 115/417 (27.6) 48/417 (11.5)    Total 4032 1572/4032 (39.0) 1723/4032 (42.7) 737/4032 (18.3) 104/4032 (2.6)     14  Version 1.1 22/02/19 Figure 2. Forest plots showing the odds ratios for 30-day mortality for different types of infection. (Example)   Table 4. Effect of post-operative infection on hospital length of stay.  Univariate (unadjusted) linear regression models for hospital length of stay in days. Data presented as mean (SD) with beta coefficients and 95% confidence intervals (CI).  Hospital length of stay n= Mean (SD) b coefficient (95% CI) p-value No infection  -  Infection Superficial surgical site    Deep surgical site    Body cavity    Pneumonia    Urinary tract    Bloodstream    Total       Surgical incisionSurgical abscessUTIURTIPneumoniaPeritonitisOsteomyelitisCNSOtherInfection3.02 (2.24, 4.08)2.01 (0.89, 4.55)2.39 (1.59, 3.59)9.81 (4.67, 20.57)12.05 (9.17, 15.85)30.70 (19.48, 48.37)5.23 (0.69, 39.68)23.53 (9.41, 58.88)8.85 (6.64, 11.80)OR (95% CI)  1.01 .05 10 2530-day mortality OR (95% CI) 15  Version 1.1 22/02/19 Supplementary Figure S2. Paper case record form (CRF) for International Surgical Outcomes Study.  16  Version 1.1 22/02/19  

International Surgical Outcomes Study (ISOS) sub-study: post-operative infection (Statistical Analysis Plan)

https://qmro.qmul.ac.uk/xmlui/bitstream/handle/123456789/65489/International%20Surgical%20Outcomes.pdf?sequence=2&isAllowed=y

International Surgical Outcomes Study (ISOS) sub-study: post-operative infection (Statistical Analysis Plan)

Abstract

Similar works

Full text

Available Versions

Queen Mary Research Online